BioTwin ApS: Financial statements 2024
CVR: 44030179
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
BioTwin ApS (CVR 44030179) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 0 and a net result of DKK 384. Equity in the 2024 report amounted to DKK 4,835,779. The solvency ratio was 100%.
- Revenue
- DKK 0
- Gross Profit
- DKK 0
- Profit/Loss
- DKK 384
- Equity
- DKK 4,835,779
- Total Assets
- DKK 4,835,779
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
BioTwin ApS has published its interim report for the period May 2, 2023 – December 31, 2023.
About BioTwin ApS
BioTwin ApS is a Danish company of the type Anpartsselskab based in Hørsholm, founded in 2023. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Sune Schmølker. The company is owned by Sune Schmølker. In 2025, the company reported a gross profit of DKK -35,651 and a net result of DKK 36,954,257 compared with DKK 384 the year before. Equity in the 2025 report amounted to DKK 41,790,036.